<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Nat Rev Genet</journal-id><journal-id journal-id-type="iso-abbrev">Nat Rev Genet</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Nature reviews. Genetics</journal-title></journal-title-group><issn pub-type="ppub">1471-0056</issn><issn pub-type="epub">1471-0064</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10989687</article-id><article-id pub-id-type="pmcid-ver">PMC10989687.1</article-id><article-id pub-id-type="pmcaid">10989687</article-id><article-id pub-id-type="pmcaiid">10989687</article-id><article-id pub-id-type="manuscript-id">NIHMS1977837</article-id><article-id pub-id-type="pmid">36344749</article-id><article-id pub-id-type="doi">10.1038/s41576-022-00541-1</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1977837</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1977837</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Prime editing for precise and highly versatile genome manipulation</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Chen</surname><given-names initials="PJ">Peter J.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Liu</surname><given-names initials="DR">David R.</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref><xref rid="CR1" ref-type="corresp">&#8224;</xref></contrib></contrib-group><aff id="A1"><label>1</label>Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of Harvard and MIT, Cambridge, MA, 02141, USA</aff><aff id="A2"><label>2</label>Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, 02138, USA</aff><aff id="A3"><label>3</label>Howard Hughes Medical Institute, Harvard University, Cambridge, MA, 02138, USA</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1">Author contributions</p><p id="P2">P.J.C. and D.R.L. contributed to all aspects of the manuscript.</p></fn><corresp id="CR1"><label>&#8224;</label><email>drliu@fas.harvard.edu</email></corresp><fn fn-type="COI-statement" id="FN2"><p id="P74">Competing interests</p><p id="P75">The authors have filed patent applications on gene editing technologies through the Broad Institute of MIT and Harvard. P.J.C. is currently an employee of Prime Medicine. D.R.L. is a consultant and equity owner of Beam Therapeutics, Pairwise Plants, Prime Medicine, Chroma Medicine, and Nvelop Therapeutics, companies that use or deliver genome editing or genome engineering technologies.</p></fn></author-notes><pub-date pub-type="ppub"><month>3</month><year>2023</year></pub-date><pub-date pub-type="epub"><day>07</day><month>11</month><year>2022</year></pub-date><volume>24</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">459120</issue-id><fpage>161</fpage><lpage>177</lpage><pub-history><event event-type="nihms-submitted"><date><day>25</day><month>03</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>03</day><month>04</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>03</day><month>04</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-04-21 14:25:28.713"><day>21</day><month>04</month><year>2025</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1977837.pdf"/><abstract id="ABS1"><p id="P3">Programmable gene editing tools have transformed the life sciences and have shown potential for the treatment of genetic disease. Among the CRISPR&#8211;Cas technologies that can currently make targeted DNA changes in mammalian cells, prime editors offer an unusual combination of versatility, specificity and precision. Prime editors do not require double-strand DNA breaks and can make virtually any substitution, small insertion and small deletion within the DNA of living cells. Prime editing minimally requires a programmable nickase fused to a polymerase enzyme, and an extended guide RNA that both specifies the target site and templates the desired genome edit. In this Review, we summarize prime editing strategies to generate programmed genomic changes, highlight their limitations and recent developments that circumvent these bottlenecks, and discuss applications and future directions.</p></abstract><abstract id="ABS2" abstract-type="summary"><title>Graphical Abstract</title><p id="P4">In this Review, Chen and Liu discuss the latest developments in prime editing systems, including improvements to their editing efficiency and capabilities, as well as diverse emerging applications in research and preclinical therapeutic studies.</p></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>